Specific alterations in the retinal microstructure in neovascular age-related macular degeneration under anti-VEGF therapy

被引:0
|
作者
Schneiderbauer, T. [1 ]
Ahlers, C. [1 ]
Stock, G. [1 ]
Golbaz, I. [1 ]
Schuetze, C. [1 ]
Sacu, S. [1 ]
Schmidt-Erfurth, U. [1 ]
机构
[1] Med Univ Wien, Univ Klin Augenheilkunde & Optometrie, A-1090 Vienna, Austria
来源
OPHTHALMOLOGE | 2011年 / 108卷 / 01期
关键词
Age-related macular degeneration; Optical coherence tomography (OCT); High-resolution OCT; Ranibizumab; Retinal layers; OPTICAL COHERENCE TOMOGRAPHY; RANIBIZUMAB; EYE;
D O I
10.1007/s00347-010-2182-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
High-definition raster scanning spectral-domain optical coherence tomography (SD-OCT) allows a precise assessment of retinal layers and a more detailed detection of subtle morphological alterations. The aim of this study was to observe such changes in patients with neovascular age-related macular degeneration (nAMD) under anti-VEGF therapy and to evaluate if they show characteristic and reversible properties. The study included 20 consecutive patients with untreated nAMD. SD-OCT with an axial resolution of 6 A mu m and a scan velocity of up to 25,000 A-scans/s was used for high-resolution imaging of the macular region at baseline and at months 1 and 3. Characteristic changes in the retinal microstructure were documented and analyzed. Obvious morphological changes as well as discrete intraretinal alterations showed a clear improvement until the third month following the initial ranibizumab injection. Destructions of the neurosensory retina and the outer retinal layers were partly reversible and significantly reduced after treatment was applied. SD-OCT was able to detect additional information on specific morphological alterations within the retina. These changes showed a considerable reduction under consistent treatment indicating their potential value for monitoring treatment success in antiangiogenic strategies.
引用
收藏
页码:38 / +
页数:7
相关论文
共 50 条
  • [21] Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
    Arai, Yusuke
    Takahashi, Hidenori
    Inoda, Satoru
    Tan, Xue
    Sakamoto, Shinichi
    Inoue, Yuji
    Fujino, Yujiro
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    PLOS ONE, 2020, 15 (03):
  • [22] Macular Atrophy in Patients with Neovascular Age Related Macular Degeneration Undergoing Anti-VEGF Therapy
    Abdelfattah, Nizar Saleh
    Zhang, Hongyang
    Boyer, David S.
    Sadda, Srinivas R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [23] Safety of intravitreal pegcetacoplan inpatients with neovascular age-related macular degeneration receiving anti-VEGF therapy
    Hu, Allen
    Esmaili, Daniel
    Ribiero, Ramiro
    Bliss, Caleb
    Jones, Daniel
    Brown, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [24] Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration
    Schmidt-Erfurth, Ursula
    Vogl, Wolf-Dieter
    Jampol, Lee Merrill
    Bogunovic, Hrvoje
    OPHTHALMOLOGY, 2020, 127 (09) : 1211 - 1219
  • [25] Parameters Influencing Clinical Decision Making in Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
    Seidman, Carly
    Yeung, Keel
    Tseng, Joseph J.
    Wald, Kenneth J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [26] Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
    Prea, Selwyn M.
    Chan, Elsa C.
    Dusting, Gregory J.
    Vingrys, Algis J.
    Bui, Bang V.
    Liu, Guei-Sheung
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [27] Early Changes of Retinal Morphology in Therapy of Neovascular Age-Related Macular Degeneration with Three Commonly Used Anti-VEGF Agents
    Enders, Philip
    Sitnilska, Vasilena
    Altay, Lebriz
    Fauser, Sascha
    OPHTHALMOLOGICA, 2018, 239 (01) : 45 - 51
  • [28] Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update
    Parravano, Mariacristina
    Costanzo, Eliana
    Scondotto, Giulia
    Trifiro, Gianluca
    Virgili, Gianni
    BIODRUGS, 2021, 35 (06) : 673 - 692
  • [29] Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
    Wykoff, Charles C.
    Clark, W. Lloyd
    Nielsen, Jared S.
    Brill, Joel V.
    Greene, Laurence S.
    Heggen, Cherilyn L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (02): : S3 - S15
  • [30] Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update
    Mariacristina Parravano
    Eliana Costanzo
    Giulia Scondotto
    Gianluca Trifirò
    Gianni Virgili
    BioDrugs, 2021, 35 : 673 - 692